CIK 0001738021 · Non-accelerated filer<br>Smaller reporting company
Compass Therapeutics, Inc.
Sign in to watch- Ticker
- CMPX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-500-8099
- Business address
- 80 GUEST STREET, BOSTON, MA, 02135
- Former names
- Olivia Ventures, Inc.
- 4 Grant or award Chief Operating Officer acquired 600,000 shares (grant or award)
- 10-Q Report Quarterly Report
- SC 13G Stake Amended Statement of Ownership
- SC 13D/A Stake Beneficial Ownership Report
- 4 Open-market buy Director bought 5,357,143 shares at $3.50 ($18,750,001)
- 4 Open-market buy Director bought 5,357,143 shares at $3.50 ($18,750,001)
- 8-K Event Material agreement · Other events
- 424B5 Offering Prospectus
- CERT Other Certification
- 424B5 Offering Prospectus
- 8-A12B Other Registration of Securities
- 8-K Event Results of operations · Other events
- 8-K Event Other events
- 10-Q Report Quarterly Report
- 8-K/A Event Exhibits
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- SC 13D/A Stake Beneficial Ownership Report
- S-3 Offering Registration Statement
Page 14 of 19 · 362 filings